Cargando…

Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis”

In 2021, over 100,000 people died prematurely from opioid overdoses. Neuropsychiatric and cognitive impairments are underreported comorbidities of reward dysregulation due to genetic antecedents and epigenetic insults. Recent genome-wide association studies involving millions of subjects revealed fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Braverman, Eric R., Dennen, Catherine A., Gold, Mark S., Bowirrat, Abdalla, Gupta, Ashim, Baron, David, Roy, A. Kenison, Smith, David E., Cadet, Jean Lud, Blum, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099927/
https://www.ncbi.nlm.nih.gov/pubmed/35564876
http://dx.doi.org/10.3390/ijerph19095480
_version_ 1784706727329923072
author Braverman, Eric R.
Dennen, Catherine A.
Gold, Mark S.
Bowirrat, Abdalla
Gupta, Ashim
Baron, David
Roy, A. Kenison
Smith, David E.
Cadet, Jean Lud
Blum, Kenneth
author_facet Braverman, Eric R.
Dennen, Catherine A.
Gold, Mark S.
Bowirrat, Abdalla
Gupta, Ashim
Baron, David
Roy, A. Kenison
Smith, David E.
Cadet, Jean Lud
Blum, Kenneth
author_sort Braverman, Eric R.
collection PubMed
description In 2021, over 100,000 people died prematurely from opioid overdoses. Neuropsychiatric and cognitive impairments are underreported comorbidities of reward dysregulation due to genetic antecedents and epigenetic insults. Recent genome-wide association studies involving millions of subjects revealed frequent comorbidity with substance use disorder (SUD) in a sizeable meta-analysis of depression. It found significant associations with the expression of NEGR1 in the hypothalamus and DRD2 in the nucleus accumbens, among others. However, despite the rise in SUD and neuropsychiatric illness, there are currently no standard objective brain assessments being performed on a routine basis. The rationale for encouraging a standard objective Brain Health Check (BHC) is to have extensive data available to treat clinical syndromes in psychiatric patients. The BHC would consist of a group of reliable, accurate, cost-effective, objective assessments involving the following domains: Memory, Attention, Neuropsychiatry, and Neurological Imaging. Utilizing primarily PUBMED, over 36 years of virtually all the computerized and written-based assessments of Memory, Attention, Psychiatric, and Neurological imaging were reviewed, and the following assessments are recommended for use in the BHC: Central Nervous System Vital Signs (Memory), Test of Variables of Attention (Attention), Millon Clinical Multiaxial Inventory III (Neuropsychiatric), and Quantitative Electroencephalogram/P300/Evoked Potential (Neurological Imaging). Finally, we suggest continuing research into incorporating a new standard BHC coupled with qEEG/P300/Evoked Potentials and genetically guided precision induction of “dopamine homeostasis” to diagnose and treat reward dysregulation to prevent the consequences of dopamine dysregulation from being epigenetically passed on to generations of our children.
format Online
Article
Text
id pubmed-9099927
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90999272022-05-14 Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis” Braverman, Eric R. Dennen, Catherine A. Gold, Mark S. Bowirrat, Abdalla Gupta, Ashim Baron, David Roy, A. Kenison Smith, David E. Cadet, Jean Lud Blum, Kenneth Int J Environ Res Public Health Commentary In 2021, over 100,000 people died prematurely from opioid overdoses. Neuropsychiatric and cognitive impairments are underreported comorbidities of reward dysregulation due to genetic antecedents and epigenetic insults. Recent genome-wide association studies involving millions of subjects revealed frequent comorbidity with substance use disorder (SUD) in a sizeable meta-analysis of depression. It found significant associations with the expression of NEGR1 in the hypothalamus and DRD2 in the nucleus accumbens, among others. However, despite the rise in SUD and neuropsychiatric illness, there are currently no standard objective brain assessments being performed on a routine basis. The rationale for encouraging a standard objective Brain Health Check (BHC) is to have extensive data available to treat clinical syndromes in psychiatric patients. The BHC would consist of a group of reliable, accurate, cost-effective, objective assessments involving the following domains: Memory, Attention, Neuropsychiatry, and Neurological Imaging. Utilizing primarily PUBMED, over 36 years of virtually all the computerized and written-based assessments of Memory, Attention, Psychiatric, and Neurological imaging were reviewed, and the following assessments are recommended for use in the BHC: Central Nervous System Vital Signs (Memory), Test of Variables of Attention (Attention), Millon Clinical Multiaxial Inventory III (Neuropsychiatric), and Quantitative Electroencephalogram/P300/Evoked Potential (Neurological Imaging). Finally, we suggest continuing research into incorporating a new standard BHC coupled with qEEG/P300/Evoked Potentials and genetically guided precision induction of “dopamine homeostasis” to diagnose and treat reward dysregulation to prevent the consequences of dopamine dysregulation from being epigenetically passed on to generations of our children. MDPI 2022-04-30 /pmc/articles/PMC9099927/ /pubmed/35564876 http://dx.doi.org/10.3390/ijerph19095480 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Braverman, Eric R.
Dennen, Catherine A.
Gold, Mark S.
Bowirrat, Abdalla
Gupta, Ashim
Baron, David
Roy, A. Kenison
Smith, David E.
Cadet, Jean Lud
Blum, Kenneth
Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis”
title Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis”
title_full Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis”
title_fullStr Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis”
title_full_unstemmed Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis”
title_short Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis”
title_sort proposing a “brain health checkup (bhc)” as a global potential “standard of care” to overcome reward dysregulation in primary care medicine: coupling genetic risk testing and induction of “dopamine homeostasis”
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099927/
https://www.ncbi.nlm.nih.gov/pubmed/35564876
http://dx.doi.org/10.3390/ijerph19095480
work_keys_str_mv AT bravermanericr proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis
AT dennencatherinea proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis
AT goldmarks proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis
AT bowirratabdalla proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis
AT guptaashim proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis
AT barondavid proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis
AT royakenison proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis
AT smithdavide proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis
AT cadetjeanlud proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis
AT blumkenneth proposingabrainhealthcheckupbhcasaglobalpotentialstandardofcaretoovercomerewarddysregulationinprimarycaremedicinecouplinggeneticrisktestingandinductionofdopaminehomeostasis